null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Anti-Kv1.2 Antibody [C25]

SKU STMA00232
Antibody Type Recombinant Monoclonal
Applications WB
Applications IHC
Applications ICC/IF
Reactivity Human
Reactivity Mouse
Reactivity Rat
Host Species Rabbit
Isotype IgG Kappa
$854
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Kv1.2 Antibody [C25]

Kv1.2 Antibody [C25] is a rabbit recombinant monoclonal antibody directed against Kv1.2, offered by Assay Genie for research applications. Reported applications include WB, IHC and ICC/IF. Reported reactivity: Human, Mouse and Rat. Supplied as IgG Kappa, purified by AmMag™ Ultra AT Protein A MagBeads.

Kv1.2, encoded by the KCNA2 gene, is a voltage-gated potassium channel subunit that plays a critical role in regulating neuronal excitability and synaptic transmission. Beyond its significance as a biophysical model for ion channel gating, Kv1.2 has emerged as a key modulator of brain function, with growing evidence linking KCNA2 mutations to a range of neurological disorders, including epilepsy, ataxia, and neurodevelopmental syndromes. A landmark crystallographic study resolved the Kv1.2 channel structure at 2.9 Å, revealing the open activation gate and tetrameric subunit architecture. This structural insight has become foundational for understanding the gating mechanisms of voltage-gated ion channels across the nervous system. Functionally, Kv1.2 channels are expressed in axons and presynaptic terminals, where they shape action potential propagation and modulate neurotransmitter release. By influencing both the timing and strength of synaptic communication, Kv1.2 contributes to the fine-tuning of neural circuit dynamics essential for cognition, motor control, and sensory processing. In the context of neurodegenerative disease, dysregulation of Kv1.2 activity may lead to aberrant neuronal firing, excitotoxicity, and impaired network stability—hallmarks of conditions such as Alzheimer’s disease and multiple sclerosis. As such, Kv1.2 is increasingly recognized as a potential therapeutic target for restoring electrical balance in diseased neural circuits. Due to its recombinant nature, our Human Kv1.2 Recombinant Monoclonal IgG offers high specificity and reproducibility, making it ideal for applications in immunohistochemistry, western blotting, and ion channel research. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose